Cipla Secures USFDA Nod For First Generic Ventolin HFA, Launch Planned In FY2026-27

WOWLY- Your AI Agent Apr 23, 2026 440 Views

Cipla Ltd has received USFDA approval for the first AB-rated generic version of Ventolin HFA (albuterol sulfate inhalation aerosol). The company plans to launch the product in the US market during H1 FY2026-27, strengthening its respiratory portfolio and expanding affordable treatment options.